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Abstract SelS is a newly identi¢ed selenoprotein and its gene
expression is up-regulated in the liver of Psammomys obesus
after fasting. We have examined whether SelS is regulated by
glucose deprivation and endoplasmic reticulum (ER) stress in
HepG2 cells. Glucose deprivation and the ER stress inducers
tunicamycin and thapsigargin increased SelS gene expression
and protein content several-fold in parallel with glucose-regu-
lated protein 78. The overexpression of SelS increased Min6 cell
resistance to oxidative stress-induced toxicity. These results in-
dicate that SelS is a novel member of the glucose-regulated
protein family and its function is related to the regulation of
cellular redox balance.
) 2004 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Glucose-regulated proteins (GRPs) were ¢rst identi¢ed as
being highly induced when cultured mammalian cells were
depleted of glucose [1]. Subsequently, it was discovered that
a variety of other agents, such as the protein glycosylation
inhibitor tunicamycin and the endoplasmic reticulum (ER)
Ca2þ-ATPase inhibitor thapsigargin, also up-regulate the ex-
pression of these genes [2]. These agents commonly cause dis-
turbance in the ER by the accumulation of misfolded proteins
or disruption of ER Ca2þ homeostasis. Consequently, the
cellular response to such agents or glucose starvation has
been termed the ER stress response or unfolded protein re-
sponse [3].
The GRP family so far comprises a diverse group of over
10 proteins including GRP78, GRP94 and calreticulin [4], and
the list is still growing. The majority of GRPs are localized in
the ER where they act as molecular chaperones assisting in
protein folding and assembly [4]. Studies using overexpression
or antisense oligonucleotides in tissue culture show that GRPs
protect cells from stress-induced cell death or apoptosis [5^8],
suggesting their induction under stress conditions is bene¢cial
to cell survival.
The induction mechanism by ER stress and glucose starva-
tion may di¡er depending on the particular gene or cell type.
While both tunicamycin and thapsigargin induce GRP expres-
sion in many cell types, WEHI72 lymphoma cells only re-
spond to tunicamycin but not to thapsigargin or the calcium
ionophore A23187 [9]. Furthermore, the heme oxygenase 1
(HO-1) gene was only induced by glucose deprivation through
the generation of reactive oxygen species, but not by tunica-
mycin or thapsigargin in hepatoma HepG2 cells [10,11]. These
studies suggest that three separate signaling pathways, one by
the accumulation of misfolded or underglycosylated proteins,
one elicited by ER Ca2þ depletion, and one by production of
reactive oxygen species, can induce GRP expression.
Selenoproteins characteristically contain the amino acid se-
lenocysteine, which is considered the 21st amino acid in the
genetic code, in their primary structures. In the universal ge-
netic code, 61 codons encode 20 amino acids while three co-
dons are terminators. The UGA codon has generally been
regarded as a stop codon for protein synthesis. However, in
the presence of a special secondary structure in the 3P-untrans-
lated region of the mRNA, i.e. a stem loop called SECIS
(selenocysteine inserting sequence), UGA can designate the
incorporation of selenocysteine into the polypeptide so that
protein synthesis continues through this codon until the next
in-frame stop codon is encountered [12]. Only 26 selenopro-
teins are predicted and/or demonstrated in mammals [13].
We previously identi¢ed a novel protein, Tanis, in the liver
of the obese/diabetic animal model Psammomys obesus [14].
Tanis, a type II transmembrane protein, is predominantly
localized in the ER but also found on the cell surface [15].
Tanis is also the homologue of a newly identi¢ed selenopro-
tein, SelS [13]. The hepatic expression of Tanis was inversely
correlated with plasma glucose concentration in P. obesus
after fasting [14,15]. Its promoter sequence also contains fea-
tures that are typical of many GRP genes. These have
prompted us to examine whether SelS is regulated by ER
stress. In this report, we have characterized the induction of
the SelS gene in HepG2 cells and examined its function as an
antioxidant.
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2. Materials and methods
2.1. Reagents
All tissue culture media, supplements and fetal bovine serum (FBS)
were obtained from Invitrogen (Carlsbad, CA, USA). Tunicamycin,
thapsigargin and actinomycin D were from Sigma (St. Louis, MO,
USA).
2.2. Cell culture
Hepatoma HepG2 cells were cultured in monolayer in Dulbecco’s
modi¢ed Eagle’s medium (4.5 g/l glucose) supplemented with 2 mM
glutamine, 1 mM pyruvate, 10% (v/v) heat-inactivated FBS. Min6
cells, a mouse L-cell line [16], were grown in monolayer in DMEM
(4.5 g/l glucose), 15% (v/v) heat-inactivated FBS, 60 WM 2-mercapto-
ethanol. Cells were grown in 5% CO2/95% air at 37‡C in medium that
contained antibiotics (penicillin, 75 Wg/ml; streptomycin, 50 Wg/ml).
One day before treatment, HepG2 cells were split in growth me-
dium without antibiotics in six-well plates. Cells at approximately 80%
con£uence were washed twice in phosphate-bu¡ered saline (PBS) and
incubated with serum-free DMEM containing di¡erent carbohydrates
or ER stress agents (tunicamycin, 10 Wg/ml; thapsigargin, 5 WM) for
24 h before cell harvest for analyses. For RNA stability studies, cells
were pretreated with glucose-free DMEM, 25 mM glucose DMEM
supplemented with or without tunicamycin or thapsigargin for 24 h.
Cells were then treated with the same media containing actinomycin
D (4 WM) for indicated time points and harvested for RNA analysis.
2.3. Immunoblot
After treatment with appropriate agents, HepG2 or Min6 cells were
washed twice with ice-cold PBS and lysed in 250 Wl of lysis bu¡er per
well (20 mM Tris, pH 7.5, 1% NP-40, 150 mM NaCl, 5 mM EDTA,
1 mM phenylmethylsulfonyl £uoride and a cocktail of protease inhib-
itors). Cells were scraped and transferred to microcentrifuge tubes,
incubated on ice for 30 min with intermittent mixing, and centrifuged
at 13 000Ug for 15 min at 4‡C. The supernatant was used for protein
concentration determination using bovine serum albumin as a stan-
dard. 50 Wg of protein was loaded on 12.5% polyacrylamide gels,
and transferred to polyvinylidene di£uoride for Western blots using
standard protocols. The primary anti-SelS antibody was described
previously [15] and anti-glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) was purchased from Chemicon (Victoria, Australia). Im-
munoreactive proteins were visualized using an enhanced chemilumi-
nescent detection system from Amersham Biosciences (NSW, Austra-
lia).
2.4. Quantitative real time reverse transcription polymerase chain
reaction (RT-PCR)
Following treatment of HepG2 cells, total RNA was isolated using
Trizol (Invitrogen) and concentration was determined using an Agi-
lent 2100 Bioanalyzer. cDNA was synthesized using a reverse tran-
scription system (Promega, Madison, WI, USA). SelS, GRP78, and
cyclophilin transcripts were quanti¢ed using real time RT-PCR on an
ABI Prism 7700 sequence detector. Primer sequences for SelS were 5P-
GTTGCGTTGAATGATGTCTTCCT-3P (forward) and 5P-AGAAA-
CAAACCCCATCAACTGT-3P (reverse), for GRP78 were 5P-GG-
TGACCTGGTACTGCTTGATG-3P (forward) and 5P-CCTTGG-
ATTCAGTTTGGTCATG-3P (reverse) and for cyclophilin were 5P-
CCCACCGTGTTCTTCGACA-3P (forward) and 5P-CCAGTGC-
TCAGAGCTCGAAA-3P (reverse). PCR conditions were 50‡C for
2 min, 95‡C for 10 min followed by 40 cycles of 95‡C for 15 s and
60‡C for 1 min. Under the conditions used, the PCR reactions were
linear with the amount of cDNA input for all three genes (data not
shown). All gene expression data are expressed as arbitrary units.
2.5. Plasmid construction, transient transfection and promoter activity
assays
To make a reporter construct containing the SelS promoter, the
SelS promoter region, i.e. 31073 bp to +39 bp, was ampli¢ed using
the GC-2 PCR kit (BD Biosciences, NSW, Australia) using human
genomic DNA as template. The PCR forward and reverse primers
incorporated the restriction sites MluI and XhoI, respectively. The
PCR products were ligated into the pGL3 basic ¢re£y luciferase vec-
tor (Promega) and the sequence was con¢rmed by DNA sequencing.
The plasmid pRL-SV40 (Promega), which contains the Renilla lucif-
erase gene, was used as an internal control for co-transfections.
HepG2 cells were grown in 12-well plates to V70% con£uence for
co-transfection with 0.7 Wg of the reporter construct and 0.07 Wg of
the control plasmid per well using LipofectAMINE Plus (Invitrogen).
Twenty-four hours post transfection, cells were washed twice in PBS
and treated with serum-free DMEM containing 25 mM glucose sup-
plemented with tunicamycin (10 Wg/ml) or thapsigargin (5 WM) for
24 h. The cells were lysed in the passive lysis bu¡er for ¢re£y lucif-
erase and Renilla luciferase activity assays using the dual-luciferase
system (Promega). Assays were done in duplicate with a luminometer
and high reproducibility was obtained. Promoter activity was ex-
pressed as the ratio of ¢re£y luciferase to Renilla luciferase activities
with the ratio in glucose treatment being arbitrarily de¢ned as 1.
2.6. SelS overexpression and cell viability assays in Min6 cells
To make a construct for SelS overexpression in mammalian cells,
the open reading frame plus the 3P-untranslated region of SelS mRNA
was ampli¢ed from HepG2 cell cDNA using the forward primer 5P-
CGGCGGATCCCATGGAACGCCAAGA-3P and reverse primer 5P-
AATTGAATTCCATAAATCTCCTTG-3P. The PCR product was di-
gested with BamHI and EcoRI and ligated into the vector pCMV-
Tag2a (Stratagene, La Jolla, CA, USA). The insert in the plasmid was
con¢rmed by DNA sequencing. Min6 cells were transiently trans-
fected using LipofectAMINE Plus (Invitrogen) with the SelS construct
or a control plasmid that encoded green £uorescent protein (GFP). To
ensure the supply of selenium for the synthesis of selenoproteins in the
cells, culture medium was supplemented with 1 WM sodium selenite
after transfection. Twenty-four hours post transfection, cells were
treated with H2O2 for 18 h. Cell viability was assayed by the 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) meth-
od [17]. Brie£y, cells were incubated in serum-free DMEM containing
0.5 mg/ml MTT for 45 min at 37‡C. During this period MTT was
cleaved in the mitochondria of viable cells. The blue MTT formazan
formed was dissolved in 0.04 M HCl in isopropanol, and the absor-
bance was determined at 570 nm (test wavelength) and 630 nm (refer-
ence wavelength) using a spectrophotometer. The results were graphed
as percentage of viable cells with cells treated with vehicle only set at
100%.
2.7. Statistical analysis
All experiments were done at least twice each with three replicates.
Data were expressed as meanSS.E.M. and were analyzed by analysis
of variance. Di¡erences were considered signi¢cant at P6 0.05.
3. Results
3.1. Induction of SelS protein and mRNA by glucose
deprivation
The distinct feature of glucose-regulated proteins is their
induction by glucose deprivation in cell culture [4]. To inves-
tigate the possibility that SelS was a novel member of the
glucose-regulated protein family, we treated HepG2 cells
with a range of glucose concentrations in serum-free
DMEM for 24 h. In low glucose media (0.5 or 2 mM), SelS
protein content was increased several-fold as compared with
cells treated with high glucose media (15 or 25 mM) (Fig. 1a).
A time course study indicated that the induction of SelS pro-
tein by low glucose was a slow process with a lag phase of
8^12 h (Fig. 1b). Consistent with previous reports [10,11], the
level of the housekeeping enzyme GAPDH was not a¡ected
by glucose concentrations in the medium (Fig. 1a,b).
The increase in SelS protein content upon low glucose treat-
ment could potentially be due to an increase in protein trans-
lation or mRNA amount. To di¡erentiate these two processes,
we measured SelS mRNA content. SelS mRNA increased with
decreasing glucose in a concentration-dependent manner be-
tween 0.5 and 15 mM (Fig. 1c). Compared with 25 mM glu-
cose, cells treated with 0.5, 2 mM and 5 mM glucose had 4.4,
3.0, and 1.7 times the amount of SelS mRNA, respectively.
These changes in mRNA levels were similar to those in pro-
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tein content, and demonstrated enhanced mRNA content was
responsible for the increased SelS protein levels during low
glucose treatment. The threshold of glucose concentration
for the induction was 2^5 mM. As expected, the housekeeping
gene cyclophilin mRNA was not a¡ected by glucose concen-
trations (Fig. 1d).
3.2. Carbohydrate speci¢city in SelS induction
Mammalian cells have the ability to use alternative carbo-
hydrates as their energy source. To investigate SelS gene in-
duction by other carbohydrates, we treated HepG2 cells for
24 h in serum- and glucose-free DMEM supplemented with
various monosaccharides (25 mM). Glucose deprivation in-
creased SelS protein content several-fold, and this induction
was abolished by fructose, galactose and man-nose (Fig. 2a).
In contrast, the addition of non-metabolizable 3-O-methylglu-
cose did not block the induction by glucose starvation. The
level of GAPDH protein was not a¡ected by these treatments
(Fig. 2a). SelS mRNA was four- to ¢ve-fold higher in cells
treated without carbohydrate or with 3-O-methylglucose when
compared with cells treated with glucose, fructose and man-
nose (Fig. 2b). Galactose appeared to be slightly less e¡ective
in suppressing SelS expression, indicating that it may be a less
preferred carbohydrate for these cells. GRP78, which has been
shown to be strongly induced by glucose starvation in HepG2
and many other cell types, was used as a positive control for
this experiment. The response of GRP78 to carbohydrate
treatments was almost in quantitative parallel with that of
SelS (Fig. 2b). On the other hand, the expression of cyclo-
philin was decreased slightly by glucose starvation and 3-O-
methylglucose (24^33%) (Fig. 2b).
3.3. Induction of SelS expression by ER stress
As shown above, SelS expression was highly up-regulated
by glucose deprivation in HepG2 cells. Glucose starvation can
activate the unfolded protein response by the accumulation of
underglycosylated proteins in the ER. However, recent work
has demonstrated that some genes can also be activated by
glucose deprivation independent of the unfolded protein re-
sponse [10,11]. To further establish the induction of SelS, we
treated HepG2 cells with the ER stress agents tunicamycin
and thapsigargin, which inhibit protein glycosylation in the
ER and deplete ER calcium stores, respectively. Western
blot showed that these agents increased SelS protein levels
while having no e¡ect on GAPDH protein content (Fig.
3a). Tunicamycin and thapsigargin increased SelS and
GRP78 mRNA by three- to four- and four- to ¢ve-fold, re-
spectively. However, these agents had a minimal e¡ect on
cyclophilin mRNA content, decreasing it by at most 30%
(Fig. 3b).
3.4. Glucose deprivation and ER stress did not a¡ect SelS
mRNA stability
Increased SelS mRNA content by glucose starvation and
ER stress may be due to an increase in its gene transcription
rate and/or to an increase in its stability. To study whether
there were any changes in SelS mRNA stability, actinomycin
D, a general inhibitor of RNA transcription [10,18], was used
to block gene expression. Decay of SelS mRNA was followed
as a function of time after the addition of actinomycin D. The
half-life of SelS mRNA was 5.7 h for high glucose, 6.7 h for
glucose-free, 6.1 h for tunicamycin and 6.8 h for thapsigargin
treatments (Fig. 4). There was no statistical signi¢cance be-
tween these four treatments at any of the time points, indicat-
ing that increased SelS mRNA content following glucose dep-
rivation and ER stress was not due to enhanced mRNA
stability.
Fig. 1. Induction of SelS protein and mRNA by glucose deprivation. HepG2 cells were treated with serum-free DMEM containing di¡erent
concentrations of glucose for 24 h (a,c,d) or treated with DMEM containing 0.5 mM glucose for the indicated length of time (b). Cells were
analyzed for SelS and GAPDH proteins (a,b) or for SelS (c) and cyclophilin (d) transcripts. ; ; P6 0.001 when compared with 25 mM glu-
cose.
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3.5. The SelS promoter contains an ER stress response element
(ERSE) and is activated by ER stress
One feature shared by GRP promoters is a GC-rich region
immediately upstream of the transcription start site [4]. We
identi¢ed the SelS upstream sequence from GenBank (acces-
sion number AC023024.6) and the 3196 to +66 region is
shown in Fig. 5a. This region is indeed highly GC-rich. For
many GRP genes, there exist up to three copies of the ERSE
within this GC-rich region. This motif, while not strictly con-
served, has the consensus sequence CCAAT(N9)CCACG
(where N9 is nine often GC-rich nucleotides) and is critical
for GRP induction under ER stress conditions [19,20]. The
SelS promoter contains the sequence GGATT(N9)CCACG
which is similar to the consensus GRP ERSE motif in verte-
brates and almost identical to the ERSE found in GRP78 of
Spinacia oleracea (Fig. 5b) [19].
We cloned the 31073 bp to +39 bp region of the SelS
promoter into a ¢re£y luciferase reporter construct for pro-
moter activity studies. Reporter assays indicated that the pro-
moter was activated three- to four-fold by tunicamycin and
Fig. 3. Induction of SelS expression by ER stress. HepG2 cells were
treated with serum-free DMEM containing 25 mM glucose, or 25
mM glucose supplemented with tunicamycin or thapsigargin for
24 h. a: SelS and GAPDH Western blots. b: SelS, GRP78 and
cyclophilin mRNA. *P6 0.01 when compared with glucose DMEM.
Fig. 4. Glucose deprivation and ER stress did not a¡ect SelS
mRNA stability. Ps 0.05 for all time points.
Fig. 2. E¡ect of monosaccharides on SelS expression. HepG2 cells were treated with serum-free DMEM containing the indicated monosaccha-
ride (25 mM) for 24 h. a: SelS and GAPDH protein levels. b: SelS, GRP78 and cyclophilin mRNA levels. *P6 0.01, #P6 0.05 when com-
pared with glucose DMEM.
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thapsigargin (Fig. 5c). This magnitude was comparable to the
induction of the endogenous SelS gene by these agents (Fig.
3). Further deletion of the promoter indicated that the 300-bp
upstream sequence was su⁄cient for ER stress induction (data
not shown).
3.6. SelS protects cells from oxidative stress
Many selenoproteins, including the glutathione peroxidases
and thioredoxin reductases [12], are enzymes that regulate
cellular redox balance. Selenoproteins W and P, which have
no enzymatic activities, also show antioxidant properties
[21,22]. We examined whether SelS had a similar role in cy-
toprotection in Min6 pancreatic L-cells, which were sensitive
to oxidative stress-induced apoptosis. Transient transfection
of Min6 cells resulted in the expression of the recombinant
SelS protein several-fold above the endogenous level (Fig. 6a);
and the expression of the control protein GFP was veri¢ed
under a £uorescence microscope (data not shown). When the
cells transfected with SelS or GFP were challenged with oxi-
dative stress, cells expressing SelS were resistant to H2O2 up
to 200 WM. In contrast, cells expressing GFP lost 42.3% of
their viability at this concentration. At 400 WM H2O2, viabil-
ity in cells expressing SelS was 3.7 times that of the cells
expressing GFP (Fig. 6b).
4. Discussion
In this report, we have demonstrated that the expression of
the selenoprotein SelS is highly inducible by glucose depriva-
tion and ER stress. We add SelS as a novel member to the
GRP family. Secondly, the overexpression of SelS gives cells
Fig. 6. SelS overexpression protected Min6 cells from oxidative
stress-induced Min6 cell death. a: Overexpression of SelS. The over-
expressed SelS carried a Flag tag at the N-terminus and was there-
fore larger than the endogenous protein on the gel. b: Cell viability.
#P6 0.05, *P6 0.01.
Fig. 5. a: The proximate SelS promoter is highly GC-rich and contains a conserved ERSE. b: Alignment of SelS ERSE with the consensus
ERSE of other glucose-regulated protein genes in vertebrates and in Spinacia oleracea (S.o.). CRT: calreticulin. c: SelS promoter-driven gene
expression under ER stress conditions. A 1-kb promoter sequence was cloned into a ¢re£y luciferase reporter construct for promoter activity
studies. *P6 0.01 when compared with DMEM containing 25 mM glucose only (control).
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resistance to oxidative stress, suggesting its function is related
to the regulation of cellular redox state. This study represents
the ¢rst report that selenoprotein can be induced by ER stress
and glucose starvation.
SelS gene expression was highly induced by glucose starva-
tion and this was completely o¡set by fructose and mannose,
but not by the non-metabolizable 3-O-methylglucose. The in-
duction had a slow response, requiring 8^12 h for accumula-
tion of SelS protein in the cells. The sugar speci¢city and time
course of induction are similar to those reported for other
GRPs such as GRP78, HO-1 and asparagine synthetase
[10,23], and support that it is the concentration of a common
sugar metabolite, perhaps glucose-6-phosphate, that is a crit-
ical regulator of gene expression. Furthermore, SelS was in-
duced by the ER stress inducers tunicamycin and thapsigar-
gin, indicating the induction involved the ER stress pathway.
Noticeably, the response of SelS to ER stress and glucose
starvation paralleled that of GRP78, one of the most exten-
sively studied GRPs (Figs. 2 and 3).
Most studies on GRP gene induction have been conducted
with cells in culture but the induction has rarely been ob-
served in vivo. Limited evidence shows the expression of
GRP78 is enhanced in vivo in embryonic mouse heart follow-
ing hypoglycemic stress or induced in fast growing tumor cells
as a result of glucose depletion and/or hypoxia [4]. It is note-
worthy that SelS expression was enhanced in the livers of P.
obesus after a 24-h fast [14,15]. The threshold glucose concen-
tration (2^5 mM) for SelS induction in vitro appears to be
much higher than those for other GRPs (6 1 mM) [10,23].
This concentration is comparable to blood glucose levels in P.
obesus in the fasted state and suggests the in vivo induction is
the result of a modest decrease in blood glucose. Such sensi-
tivity in induction makes SelS an ideal model system in the
studies of GRPs and selenoproteins.
Many members of both the selenoprotein and GRP families
function to protect cells from stress conditions. Several sele-
noproteins, including the four glutathione peroxidases and
three thioredoxin reductases, are enzymes that regulate cellu-
lar redox balance and therefore have antioxidant properties
[12]. Knockout or reduction in their activity is either lethal in
mice or produces increased susceptibility to oxidative damage
[24^27]. SelW (unknown function) and SelP (a proposed sele-
nium transport protein) also exert protection against oxidative
stress [21,22]. Similarly, typical members of the GRP family,
such as GRP78, GRP94 and calreticulin, have been shown to
protect cells from ER stress in numerous studies [5^8]. It is
therefore possible that SelS, being a selenoprotein and a GRP,
may have a similar protective function against one or more
assaults. Indeed, overexpression of SelS signi¢cantly increased
Min6 cell tolerance to oxidative stress (Fig. 6). This result
suggests that SelS, like many other selenoproteins, may also
regulate intracellular reactive oxygen species levels.
Hyperglycemia in diabetes generates elevated levels of reac-
tive oxygen species which induce tissue damage and aggravate
insulin resistance [28]. The induction of SelS in the obese/
diabetic animal model P. obesus after fasting [14] and its abil-
ity to protect cells against oxidative stress suggest it may be
implicated in the development of diabetes. The role of SelS in
the protection of pancreatic L-cells from apoptosis and in the
improvement of insulin sensitivity in the liver and peripheral
tissues through the regulation of intracellular redox state war-
rants further investigation.
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